Database

Startups

Main Industry
Health Care
Main Product/Service
The handheld thermal imaging system introduced by THERMOVISION BIOTEK, INC. will provide every woman in need with early warning signals of abnormal temperature changes caused by breast lesions, facilitating the timely seeking and receiving of further diagnostic services. We look forward to the application of this high-tech, innovative product to enhance the health and quality of life for these high-risk groups and breast cancer patients.
(The content above was translated by AI.)
Founded Year
2017
Unified Business No.
56627011
Status
Active
Number of Employees
0
Total Paid-in Capital
47,621,765 (NT$)
Location of Company
Taiwan , New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
About the Company
THERMOVISION BIOTEK, INC. (aka TVBIO) was established in June 2017 in the Industrial Technology Research Institute (ITRI) campus in Hsinchu, Taiwan. In the same year, the company entered into a technical collaboration with ThermovisionUSA, Inc. (aka TVUSA) to develop a non-invasive, safe (radiation-free), harmless, and portable breast scanning device. Meanwhile, it integrates the Medical Internet of Things (mIoT) and cloud servers to establish a remote breast healthcare platform, helping every woman use the device to receive early screening and long-term continuous monitoring services for breast diseases anytime and anywhere. This is a major breakthrough in the medical field.
(The content above was translated by AI.)



more ↓

Similar Companies

tst biomedical electronics Co., Ltd.

1. iProtin® Surface Acoustic Wave (SAW) Core Technology Platform: iProtin® is a next-generation in vitro diagnostic (IVD) solution developed by tst biomedical electronics Co., Ltd. Utilizing high-frequency reflective shear-horizontal surface acoustic wave (SH-SAW) sensor chips, it can detect real-time changes in mass and viscoelasticity on the sensing surface during antigen-antibody binding. This allows for highly sensitive quantitative or semi-quantitative detection results without the need for enzyme or fluorescent labeling. Benefiting from the unique physical properties of surface acoustic wave technology, the detection process is free from interference by blood cells, allowing the direct use of a 5 μL fingertip whole blood sample to complete high-sensitivity analysis within 3 minutes. This platform technology has obtained patents in multiple countries, features high scalability and a modular design, and can be flexibly applied to the detection of various disease biomarkers, including cardiovascular diseases, inflammatory markers, and cancer-related proteins.

2. Support for Customized Development and OEM/ODM Collaboration Models: tst biomedical electronics Co., Ltd. provides one-stop manufacturing services ranging from wafer fabrication to diagnostic biochips, assisting customers in rapidly achieving commercialization. We possess patented cavity packaging technology, which can effectively protect the surface acoustic wave sensor chip and enhance signal stability and reliability; paired with 10 nL high-precision biomaterial coating technology, it can effectively reduce production costs and facilitate biochip miniaturization. tst biomedical electronics Co., Ltd. supports customized development and OEM/ODM collaboration models, and can design chips, packaging modules, and biocoating solutions according to specific requirements, assisting academic and research institutions, startups, or corporate clients in smoothly transitioning from proof of concept and trial production to mass production.

3. The iProtin® testing platform provides API integration capabilities, which can integrate personal health indices, lifestyle habits, and medication records to achieve companion diagnostics and personalized health management. Through connections with wearable devices, health cloud platforms, or electronic medical record (EMR) systems, users can adjust exercise intensity, dietary intake, or medication dosage in real time based on test results, visualizing health data and truly implementing proactive and precise health management.
(The content above was translated by AI.)
回頁面最頂端